Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
OS Therapies Inc. is a biopharmaceutical company developing innovative immunotherapies and targeted treatments for osteosarcoma and other solid tumors. Its pipeline includes OST-HER2, an immunotherapy for rare cancers, and OST-tADC, a tunable antibody-drug conjugate platform targeting multiple cancers. The company focuses on clinical-stage development, leveraging proprietary technology, strategic collaborations, and regulatory designations to address unmet medical needs in oncology.
This description was generated via AI from an annual report. Updated about 1 year ago.